Intracellular signaling pathways and size, shape, and rupture history of human intracranial aneurysms

Neurosurgery

Volumn 70, Issue 6, 2012, Pages 1565-1572

  Laaksamo, Elisa ^a   Ramachandran, Manasi ^a   Frösen, Juhana ^a,b   Tulamo, Riikka ^a   Baumann, Marc ^c   Friedlander, Robert M ^d   Harbaugh, Robert E ^e   Hernesniemi, Juha ^a,b   Niemelä, Mika ^a,b   Raghavan, Madhavan L ^a   Laakso, Aki ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b University of Iowa   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Akt; apoptosis; Bad protein; CREB; Intracranial aneurysm; mTOR; Signal transduction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN KINASE B; PROTEIN P54; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANEURYSM RUPTURE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR STRESS SIGNAL; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DOWN REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INTRACELLULAR SIGNALING; INTRACRANIAL ANEURYSM; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WEIGHT, MASS AND SIZE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTRACRANIAL ANEURYSM; SIGNAL TRANSDUCTION;

EID: 84861532571     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31824c057e     Document Type: Article

References (35)

1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369 (9558):306-318.
2. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: A meta-analysis. Lancet Neurol. 2009;8(7):635-642.
3. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention: the International study of unruptured intracranial aneurysms Investigators. N Engl J Med. 1998;339(24):1725-1733.
4. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke. 1998;29(1):251-256.
5. Lall RR, Eddleman CS, Bendok BR, Batjer HH. Unruptured intracranial aneurysms and the assessment of rupture risk based on anatomical and morphological factors: sifting through the sands of data. Neurosurg Focus. 2009; 26(5):E2.
6. Raghavan ML, Ma B, Harbaugh RE. Quantified aneurysm shape and rupture risk. J Neurosurg. 2005;102(2):355-362.
7. Kataoka K, TanedaM, Asai T, Kinoshita A, ItoM, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms: A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999;30(7):1396-1401.
8. Frösen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004;35(10):2287-2293.
9. Pentimalli L, Modesti A, Vignati A, et al. Role of apoptosis in intracranial aneurysm rupture. J Neurosurg. 2004;101(6):1018-1025.
10. Tulamo R, Frösen J, Junnikkala S, et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery. 2006;59(5):1069-1076.
11. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4): 372-380.
12. Kilic T, Sohrabifar M, Kurtkaya Ö, et al. Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery. 2005;57(5):997-1007.
13. Frösen J, Piippo A, Paetau A, et al. Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery. 2006;58(3):534-541.
14. Laaksamo E, Tulamo R, Baumann M, et al. Involvement of mitogen-activated protein kinase signaling in growth and rupture of human intracranial aneurysms. Stroke. 2008;39(3):886-892.
15. Krischek B, Kasuya H, Tajima A, et al. Network-based gene expression analysis of intracranial aneurysm tissue reveals role of antigen presenting cells. Neuroscience. 2008;154(4):1398-1407.
16. Shi C, Awad IA, Jafari N, et al. Genomics of human intracranial aneurysm wall. Stroke. 2009;40(4):1252-1261.
17. Kurki MI, Häkkinen SK, Frösen J, et al. Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: An emerging regulative role of Toll like receptor signaling and NF-kappaB, HIF1A and ETS transcription factors. Neurosurgery. 2011;68(6):1667-1676.
18. Ma B, Harbaugh RE, Raghavan ML. Three-dimensional geometrical characterization of cerebral aneurysms. Ann Biomed Eng. 2004;32(2):264-273.
19. Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond). 2008;115(7): 203-218.
20. Danial NN. BAD: undertaker by night, candyman by day. Oncogene. 2009;27 (suppl 1):S53-S70.
21. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg. 2007;45(suppl A):25A-32A.
22. Reusch JE, Watson PA. Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes. Rev Endocr Metab Disord. 2004;5(3):209-219.
23. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res. 2009;82(2):261-271.
24. Napoli C, Quehenberger O, De Nigris F, Abete P, Glass CK, Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 2000;14(3):1996-2007.
25. Bai H, Pollman MJ, Inishi Y, Gibbons GH. Regulation of vascular smooth muscle cell apoptosis: modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res. 1999;85(3):229-237.
26. Chattopadhyay A, Chiang CW, Yang E. BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest. Oncogene. 2001;20(33):4507-4518.
27. Kadirvel R, Ding YH, Dai D, Lewis DA, Cloft HJ, Kallmes DF. Molecular indices of apoptosis activation in elastase-induced aneurysms after embolization with platinum coils. Stroke. 2007;38(10):2787-2794.
28. Rosner M, Hengstschläger M. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet. 2008;17(19):2934-2948.
29. Ahmad S, Hewett PW, Wang P, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99(7):715-722.
30. Nemenoff RA, Simpson PA, Furgeson SB, et al. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res. 2008;102 (9):1036-1045.
31. Hoi Y, Meng H, Woodward SH, et al. Effects of arterial geometry on aneurysm growth: three-dimensional computational fluid dynamics study. J Neurosurg. 2004;101(4):676-681.
32. Ujiie H, Tachibana H, Hiramatsu O, et al. Effects of size and shape (aspect ratio) on the hemodynamics of saccular aneurysms: A possible index for surgical treatment of intracranial aneurysms. Neurosurgery. 1999;45(1):119-129.
33. Tokunou T, Shibata R, Kai H, et al. Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells. Circulation. 2003;108(10):1246-1252.
34. Kyriacou SK,Humphrey JD. Influence of size, shape and properties on themechanics of axisymmetric saccular aneurysms. J Biomech. 1996;29(8):1015- 1022.
35. Nyström SH. Development of intracranial aneurysms as revealed by electron microscopy. J Neurosurg. 1963;20(4):329-337.